Search Results - "de Groot, K."

EULAR recommendations for the management of primary small and medium vessel vasculitis by Mukhtyar, C, Guillevin, L, Cid, M C, Dasgupta, B, de Groot, K, Gross, W, Hauser, T, Hellmich, B, Jayne, D, Kallenberg, C G M, Merkel, P A, Raspe, H, Salvarani, C, Scott, D G I, Stegeman, C, Watts, R, Westman, K, Witter, J, Yazici, H, Luqmani, R

“…To develop European League Against Rheumatism (EULAR) recommendations for the management of small and medium vessel vasculitis. An expert group (consisting of…”
Get more information

EULAR recommendations for the management of large vessel vasculitis by Mukhtyar, C, Guillevin, L, Cid, M C, Dasgupta, B, de Groot, K, Gross, W, Hauser, T, Hellmich, B, Jayne, D, Kallenberg, C G M, Merkel, P A, Raspe, H, Salvarani, C, Scott, D G I, Stegeman, C, Watts, R, Westman, K, Witter, J, Yazici, H, Luqmani, R

“…To develop European League Against Rheumatism (EULAR) recommendations for the management of large vessel vasculitis. An expert group (10 rheumatologists, 3…”
Get more information

Letter to the editor: Risk of false newborn screening after intra-uterine exposure to ETI by De Wachter, E, Davies, JC, Simmonds, NJ, Castellani, C, de Winter-de Groot, KM, Munck, A, Proesmans, M, Southern, KW, Barben, J

Get full text

FDA-approved drug screening in patient-derived organoids demonstrates potential of drug repurposing for rare cystic fibrosis genotypes by de Poel, E., Spelier, S., Hagemeijer, M.C., van Mourik, P., Suen, S.W.F., Vonk, A.M., Brunsveld, J.E., Ithakisiou, G.N., Kruisselbrink, E., Oppelaar, H., Berkers, G., de Winter de Groot, K.M., Heida-Michel, S., Jans, S.R., van Panhuis, H., Bakker, M., van der Meer, R., Roukema, J., Dompeling, E., Weersink, E.J.M., Koppelman, G.H., Blaazer, A.R., Muijlwijk-Koezen, J.E., van der Ent, C.K., Beekman, J.M.

“…•We implemented a high-throughput 384-wells version of the functional FIS assay to screen a large number of PDIOs for compounds that enhance CFTR function.•We…”
Get full text

Optimization of performance of Dutch newborn screening for cystic fibrosis by Bouva, MJ, Dankert-Roelse, JE, van der Ploeg, CPB, Verschoof-Puite, RK, Zomer-van Ommen, DD, Gille, JJP, Jakobs, BS, Heijnen, MLA, de Winter-de Groot, KM

“…•Until 2016, Dutch NBS for CF, as implemented in 2011, showed a sensitivity of 90%.•In 2016, NBS for CF algorithm was modified, resulting in a sensitivity of…”
Get full text

Long‐term effects of ivacaftor on nonpulmonary outcomes in individuals with cystic fibrosis, heterozygous for a S1251N mutation by Burghard, M (Marcella), Berkers, G (Gitte), Ghijsen, S (Sophie), Hollander‐Kraaijeveld, FM (Francis), Winter‐de Groot, KM (Karin), Ent, CK (Kors), Heijerman, HGM (Harry), Takken, T (Tim), Hulzebos, HJ (Erik)

“…Objectives To describe the long‐term effects of ivacaftor (Kalydeco®) in individuals with cystic fibrosis (CF) on body mass index (BMI), body composition (BC),…”
Get full text

Females with cystic fibrosis have a larger decrease in sweat chloride in response to lumacaftor/ivacaftor compared to males by Aalbers, B.L., Hofland, R.W., Bronsveld, I., de Winter-de Groot, K.M., Arets, H.G.M., de Kiviet, A.C., van Oirschot-van de Ven, M.M.M., Kruijswijk, M.A., Schotman, S., Michel, S., van der Ent, C.K., Heijerman, H.G.M.

“…•Women compared to males have a larger sweat chloride response to lumacaftor/ivacaftor treatment.•The basis of this sex difference is yet unexplained.•Sweat…”
Get full text

Incorporation of tobramycin into biomimetic hydroxyapatite coating on titanium by Stigter, M, de Groot, K, Layrolle, P

“…Calcium phosphate coatings containing an antibiotic were produced on titanium alloy (Ti6Al4V) implants using a biomimetic approach. Thin, amorphous calcium…”
Get full text

Clinical effect of lumacaftor/ivacaftor in F508del homozygous CF patients with FEV1 ≥ 90% predicted at baseline by Aalbers, B.L., de Winter-de Groot, K.M., Arets, H.G.M., Hofland, R.W., de Kiviet, A.C., van Oirschot-van de Ven, M.M.M., Kruijswijk, M.A., Schotman, S., Michel, S., van der Ent, C.K., Heijerman, H.G.M.

“…•CF patients starting lumacaftor/ivacaftor with ppFEV1 ≥ 90 do not respond to treatment in ppFEV1.•There are however beneficial effects on BMI and exacerbation…”
Get full text

Biomimetic and electrolytic calcium phosphate coatings on titanium alloy: physicochemical characteristics and cell attachment by Wang, J., Layrolle, P., Stigter, M., de Groot, K.

“…Biomimetically deposited octacalcium phosphate (OCP) and carbonate apatite (BCA) as well as electrolytically deposited carbonate apatite (ECA) were considered…”
Get full text

Limited premature termination codon suppression by read-through agents in cystic fibrosis intestinal organoids by Zomer-van Ommen, D.D, Vijftigschild, L.A.W, Kruisselbrink, E, Vonk, A.M, Dekkers, J.F, Janssens, H.M, de Winter-de Groot, K.M, van der Ent, C.K, Beekman, J.M

“…Abstract Premature termination codon read-through drugs offer opportunities for treatment of multiple rare genetic diseases including cystic fibrosis. We here…”
Get full text

Nucleation of biomimetic Ca–P coatings on Ti6Al4V from a SBF×5 solution: influence of magnesium by Barrere, F, van Blitterswijk, C.A, de Groot, K, Layrolle, P

“…Biomimetic Calcium–Phosphate (Ca–P) coatings were applied by using 5 times concentrated Simulated Body Fluid (SBF×5) using Carbon Dioxide gas. This process…”
Get full text

Influence of ionic strength and carbonate on the Ca-P coating formation from SBF×5 solution by Barrere, F, van Blitterswijk, C.A, de Groot, K, Layrolle, P

“…Biomimetic calcium-phosphate (Ca-P) coatings were applied on Ti6Al4V by using simulated body fluids concentrated by a factor 5 (SBF×5). The production of SBF×5…”
Get full text

Development of comprehensive disease assessment in systemic vasculitis by Flossmann, O, Bacon, P, de Groot, K, Jayne, D, Rasmussen, N, Seo, P, Westman, K, Luqmani, R

“…The systemic vasculitides are multisystem disorders with considerable mortality and morbidity and frequent relapses. In the absence of reliable serological…”
Get full text

Preparation and Characterization of Electrodeposited Calcium Phosphate/Chitosan Coating on Ti6Al4V Plates by Wang, J., de Boer, J., de Groot, K.

“…Electrolytically deposited carbonate apatite coating demonstrates higher strength but weaker support for bone marrow stromal cell attachment than do…”
Get full text

A review paper on biomimetic calcium phosphate coatings by Lin, X, de Groot, K, Wang, D, Hu, Q, Wismeijer, D, Liu, Y

“…Biomimetic calcium phosphate coatings have been developed for bone regeneration and repair because of their biocompatibility, osteoconductivity, and easy…”
Get full text

A comparison of bone formation in biphasic calcium phosphate (BCP) and hydroxyapatite (HA) implanted in muscle and bone of dogs at different time periods by Yuan, H., van Blitterswijk, C.A., de Groot, K., de Bruijn, J.D.

“…Physicochemical modification could implement synthetic materials into osteoinductive materials, which induce bone formation in nonosseous tissues. We hereby…”
Get full text

A bioassay using intestinal organoids to measure CFTR modulators in human plasma by Dekkers, R, Vijftigschild, L.A.W, Vonk, A.M, Kruisselbrink, E, de Winter-de Groot, K.M, Janssens, H.M, van der Ent, C.K, Beekman, J.M

“…Abstract Treatment efficacies of drugs depend on patient-specific pharmacokinetic and pharmacodynamic properties. Here, we developed an assay to measure…”
Get full text

A preliminary study on osteoinduction of two kinds of calcium phosphate ceramics by Yuan, Huipin, Kurashina, Kenji, de Bruijn, Joost D, Li, Yubao, de Groot, K, Zhang, Xingdong

“…With respect to the effect of material factors on calcium phosphate biomaterial-induced osteogenesis, the osteoinductive property of two kinds of porous…”
Get full text

Advanced biomaterials for skeletal tissue regeneration: Instructive and smart functions by Barrère, F., Mahmood, T.A., de Groot, K., van Blitterswijk, C.A.

“…The past half century has seen explosive growth in the use of medical implants. Orthopedic, cardiac, oral, maxillofacial and plastic surgeons are examples of…”
Get full text